LTF and Alzheimer disease: In two cohorts, salivary lactoferrin levels were significantly lower in MCI-PET positive and AD groups compared to FTD patients and cognitively healthy subjects from cohort 1, healthy controls and MCI-PET negative patients from cohort 2.